文献速递冠心病

全动脉化血运重建与非全动脉化血运重建的长期结局比较

Long-term Outcomes Associated With Total Arterial Revascularization vs Non-Total Arterial Revascularization.
PubMed 文献 · JAMA Cardiol · 2020-01-01

匹配后2132对患者分析显示,TAR与主要心脑血管不良事件(HR 0.78,95%CI 0.68-0.89)、死亡(HR 0.80,95%CI 0.66-0.97)和心肌梗死(HR 0.69,95%CI 0.51-0.92)风险降低相关,卒中与再次血运重建无差异。

要点

  • TAR与死亡风险降低20%相关(HR 0.80,95%CI 0.66-0.97)。

核心结论

  • 全动脉化血运重建与长期主要心脑血管不良事件、死亡和心肌梗死风险降低相关。
  • 对于预期寿命合理的CABG患者,全动脉化血运重建可能是首选术式。

研究设计与样本

  • 多中心基于人群的倾向评分匹配队列研究,纳入2008年10月至2017年3月加拿大安大略省接受首次孤立CABG且至少使用1根动脉桥的患者。

主要发现

  • 8年随访中TAR与主要心脑血管不良事件风险降低相关(HR 0.78,95%CI 0.68-0.89)。
  • TAR与死亡风险降低相关(HR 0.80,95%CI 0.66-0.97)。
  • TAR与心肌梗死风险降低相关(HR 0.69,95%CI 0.51-0.92)。
  • 卒中与再次血运重建在两组间无差异。

临床怎么用

  • 对于预期寿命合理、需行CABG的多支冠状动脉病变患者,可考虑全动脉化血运重建以改善长期预后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The optimal conduits for coronary artery bypass grafting (CABG) remain controversial in multivessel coronary artery disease. OBJECTIVE: To compare the long-term clinical outcomes of total arterial revascularization (TAR) vs non-TAR (CABG with at least 1 arterial and 1 saphenous vein graft) in a multicenter population-based study. DESIGN, SETTING, AND PARTICIPANTS: This multicenter population-based cohort study using propensity score matching took place from October 2008 to March 2017 in Ontario, Canada, with a mean and maximum follow-up of 4.6 and 9.0 years, respectively. Individuals with primary isolated CABG were identified, with at least 1 arterial graft. Exclusion criteria were individuals from out of province and younger than 18 years. Patients undergoing a cardiac reoperation or those in cardiogenic shock were also excluded because these conditions would potentially bias the surgeon toward not performing TAR. Analysis began April 2019. EXPOSURES: Total arterial revascularization. MAIN OUTCOMES AND MEASURES: Primary outcome was time to first event of a composite of death, myocardial infarction, stroke, or repeated revascularization (major adverse cardiac and cerebrovascular events). Secondary outcomes included the individual components of the primary outcome. RESULTS: Of 49 404 individuals with primary isolated CABG, 2433 (4.9%) received TAR, with the total number of bypasses being 2, 3, and 4 or more vessels in 1521 (62.5%), 865 (35.6%), and 47 individuals (1.9%), respectively. The mean (SD) age was 61.2 (10.4) years and 1983 (81.5%) were men. After propensity score matching, 2132 patient pairs were formed, with equal total number of bypasses (mean [SD], 2.4 [0.5]) but with more arterial grafts in the TAR group (mean [SD], 2.4 [0.5] vs 1.2 [0.4]; P < .01). In-hospital death (15 [0.7%] vs 21 [1.0%]; P = .32) did not differ between TAR vs non-TAR groups after propensity score matching. Throughout 8 years, TAR was associated with improved freedom from major adverse cardiac and cerebrovascular events (hazard ratio, 0.78; 95% CI, 0.68-0.89), death (hazard ratio, 0.80; 95% CI, 0.66-0.97), and myocardial infarction (hazard ratio, 0.69; 95% CI, 0.51-0.92). There was no difference in stroke and repeated revascularization. CONCLUSIONS AND RELEVANCE: Total arterial revascularization was associated with improved long-term freedom from major adverse cardiac and cerebrovascular events, death, and myocardial infarction and may be the procedure of choice for patients with reasonable life expectancy requiring CABG.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Rocha RV, Tam DY, Karkhanis R, et al. Long-term Outcomes Associated With Total Arterial Revascularization vs Non-Total Arterial Revascularization. JAMA Cardiol. 2020. PMID: 32074240. doi:10.1001/jamacardio.2019.6104

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。